Citizens JMP raised the firm’s price target on Cushman & Wakefield to $16 from $15 and keeps an Outperform rating on the shares. Cushman & Wakefield’s Q2 report validates the merits of management’s strategic plan, based on strengthening the balance sheet, investing in producers, and leveraging its global capabilities to retain and grow its customer relationships, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CWK:
